GrannumRSantMDFRCS, FACS

Female Urology/Pelvic Medicine & Reconstructive Surgery, Infections & Inflammation, Surgical Oncology

Professor of Urology, Tufts University School of Medicine

Dr. Sant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Tufts Medical CenterResidency, Urology, 1979 - 1982
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 1973 - 1975
University of Dublin Trinity CollegeClass of 1971

PubMed

Clinical use of nadofaragene firadenovec-vncg.
Badrinath R Konety, Neal D Shore, Grannum R Sant
Therapeutic Advances in Urology. 2024-09-17
BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population.
Jason Alter, Ronald Tutrone, Christian J Ray, Sonia Kumar, Grannum Sant
Journal of the National Comprehensive Cancer Network. 2024-04-05
Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.
Ronald Tutrone, Ben Lowentritt, Brian Neuman, Michael J Donovan, Elliot Hallmark
Prostate Cancer and Prostatic Diseases. 2024-03-01

Cellanyx Publishes Clinical Proof-of-Concept Study in Urology of First-in-Class Live Tumor Cell, Phenotypic Biomarker Test to Risk Stratify Prostate Cancer PatientsNovember 21st, 2018
Exosome Diagnostics Appoints Accomplished Urologist, Grannum Sant, MD, FRCS, FACS, as Head of Medical AffairsMarch 21st, 2018

Interstitial Cystitis Clinical Research Network (ICCRN)National Institute Of Diabetes And Digestive And Kidney Diseases2003
Interstitial Cystitis Trials GroupNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2003